Cooper Companies, Inc. COO

New facility expands hands-on learning opportunities and strengthens connections between education, industry and patient care CooperVision Contact Lens Centre of Excellence The new CooperVision Contact Lens Centre of Excellence at Newnham Campus provides students with experiences that reflect today’s evolving eye care environment. TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- As the demand for vision care continues to grow, preparing the next generation of eye care professionals has never been mor

Activist campaigns tend to surface when a stock’s performance no longer matches its story, and The Cooper Companies, Inc. (NASDAQ:COO) is a case in point. In mid-September 2026, Jana Partners, which built its stake in the contact lens maker roughly a year ago. It began pushing Cooper to replace CEO Albert White and its board […]

Cooper Companies (COO) just opened The Vision Centre in Southampton, a global hub that brings together research, clinical work, pilot manufacturing, and advanced technology to help move new contact lens products toward market more quickly. The backdrop for this new hub is a share price that has retreated sharply over 2026. Cooper Companies has a 30 day share price return of down 23.8% and a year to date share price return of down 31.7%, while the 1 year total shareholder return is down 18%...

With marginal growth across key metrics during the third quarter, The Cooper Companies Inc. (NASDAQ:COO) also finalized its strategic review process, which was initially announced in December last year. In Cooper Companies (COO) Bets on Fertility Growth Despite Weakness in CooperVision, we highlighted the company’s 1% year-over-year topline growth during the recently reported quarter, which […]

The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye CareSAN RAMON, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today reinforced its commitment to accelerate growth at CooperVision with the opening of its new global innovation hub, The Vision Centre, and the announcement of six major product advancements that have been accelerated to launch over the next several years: The build-out of the world's first & only complete family of 1-d

CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced six major product advancements that have been accelerated to launch over the next several years. The announcements were made as CooperVision brings together research and development, clinical expertise, pilot manufacturing, advanced technologies, and commercial capabilities to accelerate the development and commercialization of breakthrough solutions

Citing “chronic underperformance,” Jana Partners is calling for new leadership and for the company to evaluate the sale of its fertility and medical device assets.

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

For almost nine months, The Cooper Companies, Inc. (NASDAQ:COO) has been trying to sell its CooperSurgical unit. But on September 9, 2026, the company ended the strategic review it had launched in December 2025 and decided to keep the business. The reason is that the bids received were not in shareholders’ interest and reflected a […]

As Cooper Companies has lagged behind its industry peers over the past year, Wall Street analysts maintain a cautious outlook on its prospects.

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

Cooper Cos. stock rises as activist investor Jana Partners calls for the company to search for a new CEO and sell a key business segment.

In September 2026, The Cooper Companies completed a broad strategic review, ultimately deciding to retain CooperSurgical after assessing potential sale offers, while also outlining revised capital allocation plans and operational initiatives for CooperVision and CooperSurgical. The Board cited temporary factors such as a new competitor in non-hormonal IUDs and the impact of recent fertility litigation settlements as reasons for a perceived valuation gap that made selling CooperSurgical less...

The medical devices maker took a 5% hit on its stock before two big pieces of news—a guidance cut and the decision not to sell its women’s health business.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

The Cooper Companies, Inc. (NASDAQ:COO) cut its fiscal 2026 profit and revenue forecasts after weaker-than-expected demand for contact lenses weighed on its CooperVision business. The company now expects adjusted earnings of $4.51–$4.55 per share, down from its previous forecast of $4.58–$4.66, while revenue guidance was reduced to $4.23–$4.25 billion from $4.29–$4.32 billion. Third-quarter revenue came in […]